buprenorphine sandoz 8 mg
sandoz (2) - buprenorfinhydroklorid - sublingvaltablett - 8 mg
irinotecan accord 20 mg/ ml
accord healthcare b.v. - irinotekanhydrokloridtrihydrat - konsentrat til infusjonsvæske, oppløsning - 20 mg/ ml
subutex 8 mg
indivior europe limited - buprenorfinhydroklorid - sublingvaltablett - 8 mg
subutex 2 mg
indivior europe limited - buprenorfinhydroklorid - sublingvaltablett - 2 mg
valsartan/hydrochlorthiazid actavis 80 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 80 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 160 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 160 mg / 25 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg
valsartan/hydrochlorthiazid actavis 320 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 320 mg / 25 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 320 mg / 25 mg
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidonpalmitat - schizofreni - psykoleptiske - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.